Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: A randomized crossover study for the treatment of symptomatic oral lichen planus

Journal of the American Academy of Dermatology

Volumn 47, Issue 2, 2002, Pages 271-279

  Hegarty, A M ^a   Hodgson, T A ^a   Lewsey, J D ^a   Porter, S R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE SODIUM PHOSPHATE; FLUTICASONE PROPIONATE;

ADULT; AEROSOL; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; LICHEN PLANUS; MALE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SORE THROAT; SYMPTOMATOLOGY; THRUSH; TONGUE DISEASE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 0036696310     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120922     Document Type: Article

References (41)

1. Axell T. Occurrence of leukoplakia and some other white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol 1987;15:46-51.
2. Axell T, Rundquist L. Oral lichen planus - a demographic study. Community Dent Oral Epidemiol 1987;15:52-6.
3. Altman J, Perry HO. The variations and course of lichen planus. Arch Dermatol 1961;84:179-1.
4. Carozza M, Carbone M, Gandolfo S. Lichen planus and lichenoid lesions. In: Porter SR, Scully C, editors. Innovations and developments in noninvasive orofacial health care. Science Reviews: Northwood; 1996. p. 97-108.
5. Carozzo M, Gandolfo S. The management of oral lichen planus. Oral Diseases 1999;5:196-205.
6. Holmstrup P, Schiotz AW, Hyug D, Westergaard W. Effect of dental plaque control on gingival lichen planus. Oral Surg Oral Med Oral Pathol 1990;69:585-90.
7. Scully C, Beyli M, Ferreiro M, Ficarra G, Gill Y, Griffiths M, et al. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9:86-122.
8. Chan ES-Y, Thornhill M, Zakrzewska J. Interventions for treating oral lichen planus. In: The Cochrane Library, Issue 4, 1999. Oxford: Update Software.
9. Montgomery D. Design and analysis of experiments. 3rd ed. 1991.
10. Storms WW. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis. J Asthma 1998; 35:313-6.
11. Wang D, Duyck F, Smitz J, Clement P. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis. Allergy 1998;53:375-82.
12. Jarvis B, Faulds D. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages ≤ 500 micrograms/day in adults and adolescents with mild to moderate asthma. Drugs 1999;57: 769-803.
13. Matthews RW, Scully CM, Levers BGH, Hislop WS. Clinical evaluation of benzydamine, chlorhexidine and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg 1987;63:189-91.
14. Scott J, Huskinson EC. Graphic representation of pain. Pain 1976; 2:175-84.
15. Melzack R, Katz J, Jeans ME. The role of compensation in chronic pain: analysis using a new method of scoring. The McGill Pain Questionnaire. Pain 1975;23:101-12.
16. Slade GD. Derivation and validation of a short form oral health impact profile. Community Dent Oral Epidemiol 1997;25:284-90.
17. McGrath C. A review of the influences of oral health on quality of life. Int J Health Prom Educ 1999;37:116-9.
18. Thongprasom K, Luangjarmekon L, Sererat T, Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in the treatment of oral lichen planus. J Oral Pathol Med 1992;21:456-8.
19. Carbone M, Conrotto D, Carozzo M, Broccoletti R, Gandolfo S, Scully C. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophicerosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Diseases 1999;5:44-9.
20. Buajeeb W, Pobrurska C, Kraivaphan P. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:42-5.
21. Chu AC, Munn S. Fluticasone propionate in the treatment of inflammatory dermatoses. Br J Clin Pract 1995;49:131-3.
22. Johnson M. Effect of fluticasone propionate on acute and chronic inflammation. Int Arch Allergy Immunol 1995;107: 441-2.
23. Bleehan SS, Chu AC, Hamann I, Holden C, Hunter JA, Marks R. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995;133:592-7.
24. Wynn RL, Meiller TF, Crossley HL. Drug information handbook for dentistry. 4th ed. Hudson (OH): Lexi-Comp Inc; 1998. 126-7.
25. Golding-Wood DJ, Holmstrup M, Darby Y, Scalding GK, Lund VJ. The treatment of hyposmia with intranasal steroids. J Laryngol Otol 1996;110:132-5.
26. Halpern Z, Sold O, Baratz M, Konikoff F, Halak A, Gilat T. A controlled trial of beclomethasone versus betamethasone enemas in distal ulcerative colitis. J Clin Gastroenterol 1991;13:38-41.
27. Dunne JA, Travers JP. Double-blind trial comparing the efficacy of betamethasone phosphate 0.1% drops, clobetasone butyrate 0.1%, and placebo in the treatment of acute unilateral non-granulomatous uveitis. Trans Ophthalmol Soc UK 1979;99: 481-4.
28. Salam MA, Cable AR. The use of antibiotic/steroid ear drops to reduce post-operative otorrhoea and blockage of ventilation tubes: a prospective study. J Laryngol Otol 1993;107:188-9.
29. Cawson RA. Treatment of oral lichen planus with betamethasone. Br Med J 1968;1:86-9.
30. Tyldesley WR, Harding SM. Betamethasone valerate aerosol in the treatment of oral lichen planus. Br J Dermatol 1977;96:659-62.
31. Greenspan IS, Yeoman CM, Harding SM. Oral lichen planus: a double-blind comparison of treatment with betamethasone valerate aerosol and pellets. Br Dent J 1978;144:83-4.
32. Yeoman CM, Greenspan JS, Harding SM. Recurrent oral ulceration: a double-blind comparison of treatment of betamethasone valerate aerosol and placebo. Br Dent J 1978;144:114-6.
33. Merchant HW, Gangarosa LP, Glassman AB, Sobel RE. Beta-methasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol 1978;45:870-5.
34. Porter S, Scully C. Aphthous ulcers; recurrent. Clin Evidence 2000;3:606-12.
35. Voute AB, Sculten EA, Langendijk PN, Kostense PJ, Van Der Waal I. Fluocinonide in an adhesive base for treatment of oral lichen planus: a double-blind, placebo controlled study. Oral Surg Oral Med Oral Pathol 1993;75:181-5.
36. Lozada-Nur F, Miranda C, Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in Orabase and 0.05% fluocinonide ointment in Orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1994;77:598-604.
37. Sardella A, Demarosi F, Oltolina A, Rimondini L, Carassi A. Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus. Oral Diseases 1998;4:255-9.
38. Carbone M, Carrozza M, Conrotto D, Garzino Demo P, Broccoletti R, Gandolfo S. Topical treatment of atrophic-erosive oral lichen planus with clobetasol in bioadhesive gel as well as chlorhexidine and miconazole in oral gel. Minerva Stomatol 1997;46: 423-8.
39. Allenby CF, Main RA, Marsden RA, Sparkes CG. Effect on adrenal function of topical applied clobetasol propionate (Dermovate). Br Med J 1975;4:619-21.
40. Weston W, Fennessey P, Morelli J, Schwab H, Mooney J, Samson C, et al. Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol 1988;90:532-5.
41. Dempsey OJ, Coutie WJ, Wilson AM, Williams P, Lipworth BJ. Evaluation of the buccal component of systemic absorption with inhaled fluticasone propionate. Thorax 1999;54:614-7.